出处
《中国老年学杂志》
CAS
CSCD
北大核心
2009年第2期251-253,共3页
Chinese Journal of Gerontology
基金
河南省科技厅资助项目(072103810403)
河南省卫生厅资助项目(200702009)
参考文献19
-
1Sergeant N, Bretteville A, Hamdane M, et al. Biochemistry of tau in Alzheimer's disease and related neurological disorders [ J ]. Expert Rev Proteomics,2008 ; 5 (2) :207 -24.
-
2Boeve BF, Hutton M. Refining frontotemporal dementia with parkinsonism linked to chromosome 17 :introducing FTDP-17 (MAPT) and FTDP-17 ( PGRN ) [ J ]. Arch Neurol,2008 ;65 (4) :460-4.
-
3Jellinger KA. Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia [ J ]. Neurodegener Dis, 2008 ; 5 ( 3- 4) :118-21.
-
4Ballatore C, Lee VM, Trojanowski JQ. tau-mediated neurodegeneration in Alzheimer's disease and related disorders[ J ]. Nat Rev Neurosci ,2007;8 (9) :663-72.
-
5Perez M, Santa-Maria I ,Tortosa E, et al. The role of the VQIVYK peptide in tau protein phosphorylation [ J ]. J Neurochem, 2007 ; 103 ( 4 ) : 1447- 60.
-
6Liu Y, Liu F, Iqbal K, et al. Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease [ J ]. FEBS Lett,2008 ;582(2) :359-64.
-
7Deng Y, Li B, Liu F,et al. Regulation between O-GlcNA cylation and phospborylation of neurofilament-M and their dysregulation in Alzheimer disease[ J]. FASEB J,2008 ;22 ( 1 ) :138-45.
-
8Terwel D, Lasrado R, Snauwaert J,et al. Changed conformation of mutant tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of tau-4R/2N transgenic mice[J]. J Biol Chem,2005 ;280(5 ) :3963-73.
-
9Maeda S, Sahara N, Saito Y, et al. Granular tau oligomers as intermediates of tau filaments [ J ]. Biochemistry,2007 ;46 ( 12 ) :3856-61.
-
10de la Torte JC. Pathophysiology of neuronal enemy crisis in Alzheimer's disease[J]. Neurodegener Dis,2008 ;5 ( 34 ) : 126-32.
同被引文献46
-
1LIAO Xiaomei ZHANG Yingchun WANG Yipeng WANG Jianzhi.The effect of cdk-5 overexpression on tau phosphorylation and spatial memory of rat[J].Science China(Life Sciences),2004,47(3):251-257. 被引量:8
-
2褚文政,钱采韻.侧脑室注射链脲霉素引起大鼠脑Aβ_(1-40)和Aβ_(1-42)表达增加[J].第四军医大学学报,2005,26(15):1356-1358. 被引量:6
-
3Wang YP Wang XC Tian Q Yang Y Zhang Q Zhang JY Zhallg YC Wang ZF Wang Q Li H Wang JZ.Endogenous overproduction of beta-amyloid induces tau hyperphosphorylation and decreases the solubility of tau in N2a cells.[J].中国生物学文摘,2006,20(9):17-17. 被引量:5
-
4Sussmuth SD, Tumani H, Ecker D, et al. Amyotrophic lateral sclerosis:disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum[J]. Neurosci Lett,2003,353(1) :57-60.
-
5Strong MJ, Yang W, Strong WL, et al. Tau protein hyperphosphorylation in sporadic ALS with cognitive impairment[J]. Neurology, 2006,66 (11 ) : 1770-1771.
-
6Paladino P,Valentino F,Piccoli T,et al. Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis[J]. Eur J Neurol,2009,16(2) :257-261.
-
7Conrad C, Vianna C, Freeman M, et al. A polymorphie gene nested within an intron of the tau gene: implications for Alzheimer' s disease[J]. Proc Natl Acad Sci USA, 2002, 99 (11) :7751-7756.
-
8Glatz DC,Rujescu D, Tang Y,et al. The alternative splicing of tau exon 10 and it s regulatory proteins CLK2 and TRA2- BETA1 changes in sporadic Alzheimer's disease [J]. J Neurochem, 2006,96 (3) : 635-644.
-
9Levecque C, Elbaz A, Clavel J, et al. Association of polymorphisms in the Tau and Saitohin genes with Parkinson's disease[J]. J Neurol Neurosurg Psychiatry, 2004,75 (3) : 478- 480.
-
10Jankovic N, Kecmanovic M, Dimitrijevic R, et al. HD phenocopies-possible role of Saitohin gene[J]. Int J Neurosci, 2008,118(3):391-397.
引证文献5
-
1白杰,陈霞,谷伟,李爽,刘亚玲.Saitohin基因Q7R多态性与肌萎缩侧索硬化的相关性研究[J].临床荟萃,2010,25(4):292-294. 被引量:1
-
2袁树华,高顺宗,刘雪平,侯亮,徐松,王美霞,董传芳.胰岛素抵抗大鼠认知功能的变化及其脑组织Alzheimer样病变[J].卒中与神经疾病,2010,17(3):139-143. 被引量:7
-
3孙钦松.Tau蛋白——新型阿尔茨海默病治疗药物研发靶点[J].中国医师进修杂志,2011,34(3):73-74. 被引量:1
-
4宋扬,臧大维,汪志云.RBD与突触核蛋白病及tau蛋白病的研究进展[J].中国城乡企业卫生,2015,30(1):15-17. 被引量:1
-
5李瑞,任佩,崔双杰,路小婷.职业铝接触工人认知功能的改变及血浆中CDK5与磷酸化tau蛋白的关系[J].环境与职业医学,2016,33(7):633-637. 被引量:8
二级引证文献18
-
1刘建坤,马云青.雷帕霉素靶蛋白在糖尿病增加阿尔茨海默病发病风险机制中的作用[J].南昌大学学报(医学版),2011,51(6):82-84.
-
2邬树凯,陈峻严,高宏志,周培萱.重型创伤性颅脑损伤后认知功能障碍特征及其影响因素的初步研究[J].中国医师进修杂志,2011,34(29):26-29. 被引量:18
-
3李君.40例胰岛素抵抗患者认知功能测定及分析[J].山东医药,2011,51(51):83-84.
-
4陈婡,盛凯,谢安劼,吴滢.CCVI患者胰岛素抵抗程度与认知障碍严重程度的相关性研究[J].中医学报,2013,28(B08):194-195.
-
5韦喜,韦华,何明杰,李东,杨现莉,林尔兵,吴标良.铝染毒对大鼠血清腺苷三磷酸酶活性的影响[J].环境与职业医学,2018,35(11):1031-1034.
-
6张伟彬,阮清伟,姚锋,俞卓伟.中晚期阿尔茨海默病与血管性痴呆患者血浆Aβ及tau蛋白水平的比较研究[J].阿尔茨海默病及相关病杂志,2019,2(2):350-354. 被引量:8
-
7常庚,孙晓培,孙大勇,雷阳,李明,韩杰.肌萎缩侧索硬化患者血清氧化标记物表达水平与病情严重程度的相关性分析[J].临床荟萃,2014,29(8):856-858. 被引量:3
-
8马丽娜,李耘.胰岛素抵抗与认知功能障碍关系的研究进展[J].疑难病杂志,2014,13(10):1084-1086. 被引量:6
-
9章晓红,黄海燕,盛燕儿.糖尿病患者认知功能障碍相关危险因素分析[J].心脑血管病防治,2015,15(1):44-46. 被引量:6
-
10任佩,亢盼,李朝阳,张慧芳,牛侨.慢性铝暴露对大鼠脑皮质与外周血淋巴细胞NMDAR1的影响[J].卫生研究,2017,46(1):15-20. 被引量:2
-
1王晔,郭大文,王耀山.苍白球脑桥黑质变性[J].临床神经病学杂志,2005,18(3):228-229.
-
2赵永波,王枫.Tau蛋白与神经变性疾病关系的研究[J].中国现代神经疾病杂志,2004,4(5):313-315.
-
3李俊松,王敏,张大方.老年性痴呆动物模型研究概况[J].长春中医学院学报,2003,19(1):58-59. 被引量:1
-
4严波,王宁宇.老年性痴呆患者嗅觉功能研究进展[J].中华老年医学杂志,2005,24(1):62-63. 被引量:5
-
5李凤,陈明,李小刚.误诊为精神分裂症的额颞叶痴呆1例[J].第三军医大学学报,2013,35(22):2494-2494.
-
6汪青,朱粹青.FTDP-17与Tau基因突变[J].国外医学(老年医学分册),1999,20(6):241-243.
-
7宋扬,臧大维,汪志云.RBD与突触核蛋白病及tau蛋白病的研究进展[J].中国城乡企业卫生,2015,30(1):15-17. 被引量:1
-
8刘艳丽,宋琳,敖丽梅,王琪,谢宁.中药治疗阿尔茨海默病的实验研究进展[J].中华中医药学刊,2015,33(8):1803-1805. 被引量:5
-
9高天理,冯立群,张茁.tau蛋白在Alzheimer病病理机制中作用的研究进展[J].北京医学,2001,23(6):365-367. 被引量:1
-
10桂秋萍,朱明伟,王鲁宁.临床病理讨论 第299例——进行性记忆力减退、言语不利伴行动困难[J].中华内科杂志,2003,42(8):598-600. 被引量:1